Antibody arrays: removal of high abundance proteins is not required, but antibody availability limits protein detection. Mass spectrometry: “hypothesis-free” protein detection is affected by high ...

Drug development is such a formidable challenge that, some believe, it can only be undertaken effectively by big pharma. Time-consuming and expensive, the classic approach has been to screen vast ...

Proteomics has become an essential area in medical research, propelled by the ability to quantitatively assess proteins on a large scale using high-throughput technologies. These technologies have ...

Reverse phase protein array is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body fluids.

Scientists at Northwestern University have developed a new detection technology on the nanometer scale that could lead to the next generation of proteomic arrays and new methods for diagnosing ...

A novel reporter protein has been developed to enable the investigation of protein biogenesis in the ER and its disruption in disease. A recent research collaboration between multiple Japanese ...

CHAPEL HILL, N.C. – Researchers at the UNC School of Medicine, UNC McAllister Heart Institute, and the UNC Lineberger Comprehensive Cancer Center characterized the expression of thousands of cardiac ...